Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Anti-cancer nuclear hormone receptor-targeting compounds

US Patent 11834458 · Granted Dec 5, 2023

Estimated economic value: $3,741,000

Assignee

Inventors

View full patent text on Google Patents →